Orient wins Korean patent for HFRS diagnostic kit

Published: 2004-09-14 06:56:00

Updated: 2004-09-14 06:56:00

Orient Co. said on September 9 it has acquired a novel diagnostic kit for hemorrhagic fever with renal syndrome (HFRS), using Hantavirus nucleocapsid protein derived from insect cells.

The diagnostic kit is characterized by excellent specificity and sensitiveness as well as more convenient man...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK